18-46477710-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001384474.1(LOXHD1):​c.6584G>A​(p.Arg2195His) variant causes a missense change. The variant allele was found at a frequency of 0.0625 in 1,551,918 control chromosomes in the GnomAD database, including 3,482 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. R2195R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.047 ( 257 hom., cov: 33)
Exomes 𝑓: 0.064 ( 3225 hom. )

Consequence

LOXHD1
NM_001384474.1 missense

Scores

1
2
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 5.02

Publications

15 publications found
Variant links:
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
LOXHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 77
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Fuchs' endothelial dystrophy
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019818544).
BP6
Variant 18-46477710-C-T is Benign according to our data. Variant chr18-46477710-C-T is described in ClinVar as Benign. ClinVar VariationId is 47951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0693 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOXHD1NM_001384474.1 linkc.6584G>A p.Arg2195His missense_variant Exon 41 of 41 ENST00000642948.1 NP_001371403.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LOXHD1ENST00000642948.1 linkc.6584G>A p.Arg2195His missense_variant Exon 41 of 41 NM_001384474.1 ENSP00000496347.1 A0A2R8Y7K4

Frequencies

GnomAD3 genomes
AF:
0.0474
AC:
7212
AN:
152238
Hom.:
257
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0137
Gnomad AMI
AF:
0.182
Gnomad AMR
AF:
0.0599
Gnomad ASJ
AF:
0.0603
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.0267
Gnomad FIN
AF:
0.0227
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0709
Gnomad OTH
AF:
0.0664
GnomAD2 exomes
AF:
0.0482
AC:
7575
AN:
157258
AF XY:
0.0483
show subpopulations
Gnomad AFR exome
AF:
0.0132
Gnomad AMR exome
AF:
0.0447
Gnomad ASJ exome
AF:
0.0675
Gnomad EAS exome
AF:
0.00101
Gnomad FIN exome
AF:
0.0233
Gnomad NFE exome
AF:
0.0719
Gnomad OTH exome
AF:
0.0669
GnomAD4 exome
AF:
0.0641
AC:
89728
AN:
1399562
Hom.:
3225
Cov.:
31
AF XY:
0.0636
AC XY:
43869
AN XY:
690282
show subpopulations
African (AFR)
AF:
0.0102
AC:
321
AN:
31598
American (AMR)
AF:
0.0451
AC:
1609
AN:
35704
Ashkenazi Jewish (ASJ)
AF:
0.0672
AC:
1693
AN:
25182
East Asian (EAS)
AF:
0.000728
AC:
26
AN:
35738
South Asian (SAS)
AF:
0.0332
AC:
2632
AN:
79236
European-Finnish (FIN)
AF:
0.0239
AC:
1179
AN:
49342
Middle Eastern (MID)
AF:
0.0542
AC:
309
AN:
5698
European-Non Finnish (NFE)
AF:
0.0727
AC:
78438
AN:
1079018
Other (OTH)
AF:
0.0607
AC:
3521
AN:
58046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
6330
12659
18989
25318
31648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2886
5772
8658
11544
14430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0474
AC:
7217
AN:
152356
Hom.:
257
Cov.:
33
AF XY:
0.0449
AC XY:
3342
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.0137
AC:
568
AN:
41596
American (AMR)
AF:
0.0599
AC:
916
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0603
AC:
209
AN:
3464
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5182
South Asian (SAS)
AF:
0.0275
AC:
133
AN:
4830
European-Finnish (FIN)
AF:
0.0227
AC:
241
AN:
10624
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0710
AC:
4828
AN:
68040
Other (OTH)
AF:
0.0658
AC:
139
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
373
747
1120
1494
1867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0617
Hom.:
725
Bravo
AF:
0.0483
TwinsUK
AF:
0.0731
AC:
271
ALSPAC
AF:
0.0688
AC:
265
ESP6500AA
AF:
0.0145
AC:
20
ESP6500EA
AF:
0.0798
AC:
254
ExAC
AF:
0.0426
AC:
1120
Asia WGS
AF:
0.0180
AC:
61
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg2133His in Exon 40 of LOXHD1: This variant is not expected to have clinical s ignificance because it has been identified in 7.7% (196/2532) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs74316327). -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal recessive nonsyndromic hearing loss 77 Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.41
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.049
.;.;.;T;.;.;.;.
Eigen
Benign
0.050
Eigen_PC
Benign
0.20
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.80
T;T;T;D;D;D;D;D
MetaRNN
Benign
0.0020
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
5.0
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.4
D;.;D;.;D;D;.;.
REVEL
Benign
0.029
Sift
Benign
0.17
T;.;T;.;T;T;.;.
Sift4G
Benign
0.13
T;T;T;T;T;T;.;T
Polyphen
0.0040
.;.;.;.;B;.;.;.
Vest4
0.18
ClinPred
0.030
T
GERP RS
4.3
Varity_R
0.13
gMVP
0.30
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74316327; hg19: chr18-44057673; COSMIC: COSV56060930; API